Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review

VC Romão, JE Fonseca - Frontiers in medicine, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is the most common systemic inflammatory rheumatic disease. It is
associated with significant burden at the patient and societal level. Extensive efforts have …

[HTML][HTML] Comorbidities in patients with vitiligo: a systematic review and meta-analysis

JH Lee, HJ Ju, JM Seo, A Almurayshid, GM Kim… - Journal of Investigative …, 2023 - Elsevier
Vitiligo has been reported to be associated with a variety of diseases, but it has not been
systematically reviewed. Therefore, we aimed to identify prevalent diseases in patients with …

Beyond skin white spots: Vitiligo and associated comorbidities

Z Hu, T Wang - Frontiers in Medicine, 2023 - frontiersin.org
Vitiligo is a common depigmentation disorder of an unknown origin characterized by the
selective loss of melanocytes, resulting in typical white macules and patches. However …

[HTML][HTML] Increased risk of vitiligo following anti-tumor necrosis factor therapy: a 10-year population-based cohort study

JM Bae, M Kim, HH Lee, KJ Kim, H Shin, HJ Ju… - Journal of Investigative …, 2018 - Elsevier
Anti-tumor necrosis factor− α (anti-TNF) therapy is used to treat a wide range of chronic
inflammatory conditions. However, there has been an increasing number of reports of …

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: a nationwide population‐based cohort study

JM Seong, J Yee, HS Gwak - British journal of clinical …, 2019 - Wiley Online Library
Aims To evaluate the real‐world effect of dipeptidyl peptidase‐4 inhibitor (DPP4i) on the
incidence of autoimmune diseases (AD), including rheumatoid arthritis (RA), inflammatory …

Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study

JM Bae, KY Chung, SJ Yun, H Kim, BC Park… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Recent studies indicated that the autoimmunity of vitiligo exerts effects on cells
other than melanocytes, which confer reduced risks of both melanoma and nonmelanoma …

Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo

P Yang, M Luan, W Li, M Niu, Q He, Y Zhao… - Frontiers in …, 2023 - frontiersin.org
Background Vitiligo is a common autoimmune depigmented dermatology due to destruction
of melanocytes. Much evidence suggests that vitiligo is associated with systemic immune …

Association of particulate matter with autoimmune rheumatic diseases among adults in South Korea

JS Park, S Choi, K Kim, J Chang, SM Kim… - …, 2021 - academic.oup.com
Objective The primary objective of this study was to investigate adverse effects of ambient
particulate matter of various sizes on the incidence of the prevalent autoimmune rheumatic …

Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study

J Kim, J Chun, C Lee, K Han, S Choi… - Journal of …, 2020 - Wiley Online Library
Abstract Background and Aim The relationship between inflammatory bowel disease (IBD)
and idiopathic pulmonary fibrosis (IPF) remains unclear. We evaluated the risk for …

Pregnancy outcomes in patients with vitiligo: a nationwide population-based cohort study from Korea

KY Park, HJ Kwon, JH Wie, HH Lee, SB Cho… - Journal of the American …, 2018 - Elsevier
Background Vitiligo is a chronic autoimmune skin disorder affecting 1% of populations
worldwide. Few large-scale studies have explored adverse pregnancy outcomes in patients …